X T L Biopharmaceuticals reported $1.34M in Current Assets for its fiscal quarter ending in December of 2024.


Current Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Bioline Rx USD 31.86M 55K Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025
X T L Biopharmaceuticals USD 1.34M 647K Dec/2024